(Q22253156)

DNA topoisomerase II alpha

1 reference

tumor protein p53

1 reference

protein C-terminus binding

1 reference

I G Cowell

1

I G

Cowell

1 reference

30 March 2023

A L Okorokov

2

A L

Okorokov

1 reference

30 March 2023

S A Cutts

3

S A

Cutts

1 reference

30 March 2023

K Padget

4

K

Padget

1 reference

30 March 2023

M Bell

5

M

Bell

1 reference

30 March 2023

J Milner

6

J

Milner

1 reference

30 March 2023

C A Austin

7

C A

Experimental Cell Research

Austin

1 reference

30 March 2023

language of work or name

English

0 references

publication date

25 February 2000

0 references

published in

0 references

volume

255

0 references

page(s)

86-94

0 references

issue

1

0 references

cites work

Binding of wild-type p53 by topoisomerase II and overexpression of topoisomerase II in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Bipartite nuclear localization signals in the C terminus of human topoisomerase II alpha.

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Nuclear distribution of human DNA topoisomerase IIbeta: a nuclear targeting signal resides in the 116-residue C-terminal tail.

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Isolation and characterization of a human cDNA clone encoding a novel DNA topoisomerase II homologue from HeLa cells.

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Small peptides activate the latent sequence-specific DNA binding function of p53.

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Novel HeLa topoisomerase II is the II beta isoform: complete coding sequence and homology with other type II topoisomerases.

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Modulation of DNA Topoisomerase I Activity byp53

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Phosphorylation of the C-terminal sites of human p53 reduces non-sequence-specific DNA binding as modeled with synthetic peptides

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

A novel genetic system to detect protein-protein interactions

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

p53 modulation of TFIIH-associated nucleotide excision repair activity

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II beta

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Functional dissection of the phosphorylated termini of fission yeast DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Human cells express two differentially spliced forms of topoisomerase II beta mRNA

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Construction of an improved host strain for two hybrid screening

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Protein-protein interaction between the transcriptional repressor E4BP4 and the TBP-binding protein Dr1

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

p53 regulates the minimal promoter of the human topoisomerase IIalpha gene

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

DNA damage activates p53 through a phosphorylation-acetylation cascade

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Transcriptional repression by a novel member of the bZIP family of transcription factors

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

Immunologically distinct p53 molecules generated by alternative splicing

1 reference

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

7 January 2021

https://api.crossref.org/works/10.1006%2FEXCR.1999.4772

1 reference

7 January 2021